Wire Stories
624Plastec Technologies Reports Fiscal 2020 Financial Results
HONG KONG–(BUSINESS WIRE)–Plastec Technologies, Ltd. (OTCBB: PLTYF) (the “Company”) today reported audited financial results for the fiscal 2020 year ended December 31,...
- 695
Renesas DDR5 I3C Bus Extension and SPD Hub Devices Qualified for AMI Firmware
Expanded I3C Ecosystem Now Includes Firmware, Software, and Hardware, Accelerating Product Qualification and Adoption for DDR5 Solutions TOKYO–(BUSINESS WIRE)–#DDR5–Renesas Electronics Corporation (TSE:6723),...
- 685
UMC Files Form 20-F for 2020 with US Securities and Exchange Commission
TAIPEI, Taiwan–(BUSINESS WIRE)–United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”), today filed its 2020 annual report on Form 20-F with the US...
- 640
Almost One-third of Global Pet Care Sales to Come From E-commerce By 2026
LONDON–(BUSINESS WIRE)–#OnlinePetSales–Pet care will continue to benefit from the online retail sales boom during the pandemic, as the industry expects to record...
- 569
Mirum Pharmaceuticals and CANbridge Pharmaceuticals Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat in Greater China for Rare Liver Diseases
– CANbridge to lead development and commercialization in China; expands rare disease pipeline – Mirum is entitled to receive up to an...
- 786
Brii Biosciences Monoclonal Antibodies, BRII-196 and BRII-198, Progress to Phase 3 in NIH ACTIV-2 Trial in Ambulatory COVID-19 Patients
Independent data safety monitoring board (DSMB) formally recommends investigational combination therapy advance to Phase 3 following Phase 2 pre-specified analysis for safety...
- 597
Coupang to Announce First Quarter 2021 Results on May 12, 2021
SEOUL, South Korea–(BUSINESS WIRE)–$CPNG–Coupang, Inc. (NYSE: CPNG) will release its financial results for its first quarter ended March 31, 2021 after the...
- 635
Mirum Pharmaceuticals and CANbridge Pharmaceuticals Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat in Greater China for Rare Liver Diseases
– CANbridge to lead development and commercialization in China; expands rare disease pipeline – Mirum is entitled to receive up to an...
- 655
Embassy REIT Announces Full Year FY 2021 Results, Delivers a Resilient Performance
Distributes Rs 18,364 million and grows Net Operating Income YoY by 12% Leases 1.2 msf across 40+ deals, achieves 15% leasing spreads...
- 539
Asia-Pacific Specialty Chemicals Market (2020 to 2027) – Trend Outlook and Growth Opportunity – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Specialty Chemicals Market 2020-2027 by Application (Construction, Food & Feed, Pharmaceutical & Cosmetic, Water Treatment, Paper & Pulp, Oilfield,...
